Safety And Pharmacokinetic Aspects Of Anti- Angiogenic Therapy With Ptk787/Zk 222584 In Combination With Paclitaxel/Carboplatin In Patients With Ovarian Cancer — M-D. Li (2006) | RDL Network
Safety And Pharmacokinetic Aspects Of Anti- Angiogenic Therapy With Ptk787/Zk 222584 In Combination With Paclitaxel/Carboplatin In Patients With Ovarian Cancer
Christos Papadimitriou, D. Lazaris, Alexandros Rodolakis, Christos Kiamouris, Georgios M. Gourgoulis, Eleni Galani, E Diakomanolis, S. Michalas, Meletios A Dimopoulos
Stan B. Kaye, Steinar Aamdal, Richard D. Jones, Gilles Freyer, Éric Pujade-Lauraine, Elisabeth G.E. de Vries, Jorge Barriuso, Shahneen Sandhu, Daniel S.W. Tan, V Hartog, Bart C. Kuenen, Rita Ruijter, Gunnar B. Kristensen, Marta Nyakas, Sophie Barrett, Wendy Burke, D Pietersma, Melissa K. Stuart, Ugochi Emeribe, Epie Boven
Gerasimos Aravantinos, G. Fountzlias, P. Kosmidis, Meletios A Dimopoulos, Stathopoulos Gp, N. Pavildis, Dimitrios Bafaloukos, S. Rigatos, S. Karpathios, D. Skarlos
Discussion(0)
No comments yet. Be the first to comment.